Alpha Teknova (TKNO) Expected to Post Quarterly Earnings on Wednesday

Key Points

• Alpha Teknova is expected to report Q3 2026 results after market close on November 4. Analysts forecast a loss of $0.06 per share and revenue of $11.71 million.
• The company exceeded expectations in the prior quarter, reporting a $0.06-per-share loss versus the expected $0.08 loss and revenue of $12.19 million versus estimates of $10.95 million.
• Investor sentiment is moderately bullish: four analysts rate the stock a Buy, one rates it Hold and one Sell, with an average price target of $8.75. Shares recently traded at $7.32, up 3.0%.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) will likely be releasing its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to post earnings of ($0.06) per share and revenue of $11.71 million for the quarter. Investors can find conference call details on the company's upcoming Q3 2026 earnings report for the latest details on the call scheduled for Wednesday, November 4, 2026 at 6:00 PM ET.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.02. The firm had revenue of $12.19 million for the quarter, compared to analysts' expectations of $10.95 million. On average, analysts expect Alpha Teknova to post ($0.28) EPS for the current fiscal year and ($0.23) EPS for the next fiscal year.

Alpha Teknova Trading Up 3.0%

Shares of NASDAQ TKNO traded up $0.21 during midday trading on Wednesday, hitting $7.32. 26,603 shares of the company's stock were exchanged, compared to its average volume of 249,248. Alpha Teknova has a 12-month low of $1.91 and a 12-month high of $9.48. The business's fifty day moving average price is $7.67 and its two-hundred day moving average price is $4.83. The company has a market cap of $393.11 million, a price-to-earnings ratio of -23.61 and a beta of 0.85.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Zacks Research raised Alpha Teknova to a "hold" rating in a report on Thursday, August 6th. Roth Capital began coverage on shares of Alpha Teknova in a report on Wednesday, August 5th. They set a "buy" rating and a $7.00 price objective for the company. Wall Street Zen upgraded shares of Alpha Teknova from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. BTIG Research upgraded shares of Alpha Teknova from a "neutral" rating to a "buy" rating and set a $8.00 price objective for the company in a research note on Tuesday, August 11th. Finally, TD Cowen increased their target price on shares of Alpha Teknova from $7.00 to $11.00 and gave the stock a "buy" rating in a research note on Tuesday, October 13th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $8.75.

About Alpha Teknova

Alpha Teknova, Inc is a life sciences company that develops and manufactures critical reagents and other products used in biomedical research, biopharmaceutical development and advanced therapies. The company provides laboratory and production materials designed to support applications including cell and gene therapy, molecular diagnostics, next-generation sequencing, vaccine development and pharmaceutical manufacturing.

Its offerings include research-use-only and current Good Manufacturing Practice (cGMP) reagents, buffers, media and other custom-formulated solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.